{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:43:37Z","timestamp":1791395017171,"version":"4.3.3"},"reference-count":54,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ther. Deliv."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.4155\/tde-2017-0104","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T05:04:38Z","timestamp":1518152678000},"page":"185-204","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":56,"title":["Calcium alginate-based Antimicrobial Film Dressings for Potential Healing of Infected Foot Ulcers"],"prefix":"10.1080","volume":"9","author":[{"given":"Asif","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical, Chemical & Environmental Sciences, Faculty of Engineering & Science, University of Greenwich, MedwayCentral Ave Chatham MaritimeKentME4 4TB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Boateng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical, Chemical & Environmental Sciences, Faculty of Engineering & Science, University of Greenwich, MedwayCentral Ave Chatham MaritimeKentME4 4TB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"e_1_3_5_2_1","first-page":"44","article-title":"The burden of chronic wounds in the UK","volume":"104","author":"Posnett J","year":"2008","unstructured":"Posnett J Franks PJ . The burden of chronic wounds in the UK. Nurs. Times104, 44\u201345 (2008).","journal-title":"Nurs. Times"},{"key":"e_1_3_5_3_1","article-title":"Diabetic foot care in England: an economic etudy","author":"Kerr M","year":"2017","unstructured":"Kerr M . Diabetic foot care in England: an economic etudy. Insight Heal Econ. (2017). www.diabetes.org.uk\/Upload\/Sharedpractice\/Diabetic footcare in England, An economic case study (2017).","journal-title":"Insight Heal Econ."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2014.23.11.552"},{"key":"e_1_3_5_5_1","unstructured":"HM Treasury . Public expenditure statistical analyses 2016 (2016). www.gov.uk\/government\/statistics\/public-expenditure-statistical-analyses-2016#history."},{"key":"e_1_3_5_6_1","unstructured":"Healthcare Quality Improvement Partnership . National Diabetes Foot Care Audit Report (2014\u20132016) (2017). www.content.digital.nhs.uk\/catalogue\/PUB23525\/nati-diab-foot-care-audit-14\u201316-rep.pdf."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i4.546"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2004.06.001"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.1827"},{"issue":"3","key":"e_1_3_5_10_1","first-page":"441","article-title":"The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains","volume":"7","author":"Shanmugam P","year":"2013","unstructured":"Shanmugam P M J Susan SL . The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J. Clin. Diagn. Res.7 (3), 441\u2013445 (2013).","journal-title":"J. Clin. Diagn. Res."},{"issue":"4","key":"e_1_3_5_11_1","first-page":"389","article-title":"Staphylococcus aureus strains isolated from diabetic foot ulcers. Identification of the antibiotic resistant phenotypes","volume":"20","author":"Chita T","year":"2013","unstructured":"Chita T Muntean D Baditoiu L et al. Staphylococcus aureus strains isolated from diabetic foot ulcers. Identification of the antibiotic resistant phenotypes. Rom. J. Diabetes Nutr. Metab Dis.20 (4), 389\u2013393 (2013).","journal-title":"Rom. J. Diabetes Nutr. Metab Dis."},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2010.11.023"},{"issue":"1","key":"e_1_3_5_13_1","first-page":"6","article-title":"A review on recent trends in oral drug delivery-fast dissolving formulation technology","volume":"6","author":"Kumar S","year":"2012","unstructured":"Kumar S Gupta SK Sharma PK . A review on recent trends in oral drug delivery-fast dissolving formulation technology. Adv. Biol. Res. (Rennes)6 (1), 6\u201313 (2012).","journal-title":"Adv. Biol. Res. (Rennes)"},{"key":"e_1_3_5_14_1","first-page":"377","volume-title":"WoundHealing\u2013New Insights into Ancient Challenges","author":"Sarheed O","year":"2016","unstructured":"Sarheed O Ahmed A Shouqair D Boateng J . Antimicrobial dressings for improving wound healing. In : WoundHealing\u2013New Insights into Ancient Challenges. AlexandrescuVA (Ed.). InTech, Rijeka, Croatia, 377\u2013402 (2016). www.intechopen.com\/books\/wound-healing-new-insights-into-ancient-challenges\/antimicrobial-dressings-for-improving-wound-healing."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2012.0401"},{"issue":"4","key":"e_1_3_5_16_1","first-page":"253","article-title":"Use of semiocclusive, transparent film dressings for surgical wound protection: experience in 3637 cases","volume":"76","author":"Rubio PA","year":"1991","unstructured":"Rubio PA . Use of semiocclusive, transparent film dressings for surgical wound protection: experience in 3637 cases. Int. Surg.76 (4), 253\u2013254 (1991).","journal-title":"Int. Surg."},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24068"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2015.07.037"},{"issue":"2","key":"e_1_3_5_19_1","first-page":"127","article-title":"Calcium alginate\/PVA blended nano fibre matrix for wound dressing","volume":"37","author":"Tarun K","year":"2012","unstructured":"Tarun K Gobi N . Calcium alginate\/PVA blended nano fibre matrix for wound dressing. Indian J. Fibre Text. Res.37 (2), 127\u2013132 (2012).","journal-title":"Indian J. Fibre Text. Res."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.5505\/tjtes.2013.30676"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/383270"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S17595"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.4103\/2278-344X.167660"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/jfb3020361"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.suppl_1.5"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1988.tb04058.x"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.memsci.2006.01.002"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/app.23563"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.04.047"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2014.0576"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2017.05.040"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2004.10.018"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3093(01)00345-3"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.11.045"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.05.038"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2013.09.011"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2012.07.071"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.07.034"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2011.06.003"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639040902744704"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.01.008"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/198137"},{"key":"e_1_3_5_43_1","first-page":"1","article-title":"Fluid handling properties of allevyn dressing","author":"Thomas S","year":"2007","unstructured":"Thomas S . Fluid handling properties of allevyn dressing. Wound Manage. Commun.1\u20138 (2007). www.dressings.org\/TechnicalPublications\/PDF\/S+N-Allevyn-March-2007\/Allevyn-Fluid-Handling-Properties-April-2007.pdf.","journal-title":"Wound Manage. Commun."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2011.0288"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0926-6690(01)00114-5"},{"key":"e_1_3_5_46_1","article-title":"The role of dressings in the treatment of moisture-related skin damage","author":"Thomas S","year":"2008","unstructured":"Thomas S . The role of dressings in the treatment of moisture-related skin damage. World Wide Wounds (2008). www.worldwidewounds.com\/2008\/march\/Thomas\/Maceration-and-the-role-of-dressings.html.","journal-title":"World Wide Wounds"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2016.05.014"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2016.09.023"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2012.08.014"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules190812011"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.09.085"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2004.09.014"},{"key":"e_1_3_5_53_1","unstructured":"Ataee RA Derakhshanpour J Mehrabi Tavana A Eydi A . Antibacterial effect of Agrobacterium tumefaciens calcium carbonate nanoparticles on Agrobacterium tumefaciens. 13 (2) 65\u201370 (2011)."},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2011.590496"},{"key":"e_1_3_5_55_1","author":"CIPRO\u00ae (ciprofloxacin hydrochloride) Tablets CIPRO\u00ae (ciprofloxacin*) Oral Suspension","year":"2004","unstructured":"CIPRO\u00ae (ciprofloxacin hydrochloride) Tablets CIPRO\u00ae (ciprofloxacin*) Oral Suspension . Bayer HealthCare (2004). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/19537s049,19857s031,19847se5\u2013027,20780se5\u2013013_cipro_lbl.pdf.","journal-title":"Bayer HealthCare"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/tde-2017-0104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:19:31Z","timestamp":1715980771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/tde-2017-0104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.4155\/tde-2017-0104"],"URL":"https:\/\/doi.org\/10.4155\/tde-2017-0104","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}